Ball & CO Wealth Management Inc. Puma Biotechnology, Inc. Transaction History
Ball & CO Wealth Management Inc.
- $93.3 Million
- Q1 2025
A detailed history of Ball & CO Wealth Management Inc. transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Ball & CO Wealth Management Inc. holds 3,506 shares of PBYI stock, worth $10,658. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,506
Previous 3,506
-0.0%
Holding current value
$10,658
Previous $10,000
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding PBYI
# of Institutions
111Shares Held
28.7MCall Options Held
17.9KPut Options Held
3.4K-
Vanguard Group Inc Valley Forge, PA3.67MShares$11.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.57MShares$10.9 Million0.0% of portfolio
-
Acorn Capital Advisors, LLC New York, NY2.45MShares$7.45 Million6.49% of portfolio
-
Acadian Asset Management LLC Boston, MA1.97MShares$6 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.89MShares$5.76 Million0.0% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $138M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...